GGrantIndex
← Leaderboards

Cesaltina Ferreira Lorenzoni

University Of Tx Md Anderson Can Ctr

$1,475,824
Attributed
$2,228,918
Total exposure
3
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.1M · FY202325
$2.5M$1.9M$1.3M$625K$0
'23
'24
'25

Funding mix

By agency

NIH$5,379,039 · 4

By mechanism

U54$4,249,398 · 3
U01$1,129,641 · 1

Most similar at University Of Tx Md Anderson Can Ctr

Same institution · by research overlap

Others in their field

Other Rising Stars on “Women&Apos

Research focus

Women&AposLow And Middle-Income CountriesMalignant Neoplasm Of Cervix UteriWomanTechnologyMalignant NeoplasmsPreventPoint Of CareProgramsCountryCervical Cancer ScreeningCostDiagnosisMozambiqueInfrastructureBehavioral SciencesEpidemiologyAdvanced DevelopmentCo-InfectionImageCancer EtiologyHistologicCervical DysplasiaBrazil

Grant awards (15)

The AVANÇO Research Consortium: A Mozambique/Brazil/Texas Alliance to advance novel and affordable technologies for the prevention and diagnosis of cervical cancer in women living with HIV$647,289
U54 · FY2025 · CA
Sample-to-answer HPV DNA nucleic acid test for cervical cancer screening in Mozambique$491,989
U01 · FY2025 · CA
The AVANÇO Research Consortium: A Mozambique/Brazil/Texas Alliance to advance novel and affordable technologies for the prevention and diagnosis of cervical cancer in women living with HIV$246,592
U54 · FY2025 · CA
Shared Resources Core$129,458
U54 · FY2025 · CA · contact PI
Project 2$129,458
U54 · FY2025 · CA · contact PI
The AVANÇO Research Consortium: A Mozambique/Brazil/Texas Alliance to advance novel and affordable technologies for the prevention and diagnosis of cervical cancer in women living with HIV$120,096
U54 · FY2025 · CA
Sample-to-answer HPV DNA nucleic acid test for cervical cancer screening in Mozambique$51,709
U01 · FY2025 · CA
The AVANÇO Research Consortium: A Mozambique/Brazil/Texas Alliance to advance novel and affordable technologies for the prevention and diagnosis of cervical cancer in women living with HIV$45,360
U54 · FY2025 · CA
The AVANÇO Research Consortium: A Mozambique/Brazil/Texas Alliance to advance novel and affordable technologies for the prevention and diagnosis of cervical cancer in women living with HIV$1,059,338
U54 · FY2024 · CA
Sample-to-answer HPV DNA nucleic acid test for cervical cancer screening in Mozambique$585,943
U01 · FY2024 · CA
Project 2$383,366
U54 · FY2024 · CA · contact PI
Shared Resources Core$50,920
U54 · FY2024 · CA · contact PI
The AVANÇO Research Consortium: A Mozambique/Brazil/Texas Alliance to advance novel and affordable technologies for the prevention and diagnosis of cervical cancer in women living with HIV$1,031,446
U54 · FY2023 · CA
Project 2$337,824
U54 · FY2023 · CA · contact PI
Shared Resources Core$68,251
U54 · FY2023 · CA · contact PI